On January 7, 2014, Safeguard Scientifics announced that BD (Becton, Dickinson and Company), a leading global medical company, acquired point-of-care testing innovator Alverix for $40 million, representing aggregate cash proceeds of $17.4 million for Safeguard.

Safeguard Scientifics deployed capital in Alverix in 2007, recognizing significant market opportunity for Alverix’s products, which leverage optoelectronics, offer portability and affordability, yet can also detect human error.

(Visited 414 times, 1 visits today)